These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10446488)

  • 41. The investigation and treatment of secondary anaemia.
    Davis SL; Littlewood TJ
    Blood Rev; 2012 Mar; 26(2):65-71. PubMed ID: 22133555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anemia in chronic heart failure: etiology and treatment options.
    Westenbrink BD; de Boer RA; Voors AA; van Gilst WH; van Veldhuisen DJ
    Curr Opin Cardiol; 2008 Mar; 23(2):141-7. PubMed ID: 18303527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
    Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
    Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
    Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
    Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [In vitro studies on anemia in chronic inflammatory disease: influence of interleukin-6 on human erythropoietin].
    Ratajczak MZ; Ratajczak J; Skorski T
    Pol Merkur Lekarski; 1997 Jan; 2(9):172-5. PubMed ID: 10907020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of chronic skin ulcers in individuals with anemia of chronic disease using recombinant human erythropoietin (EPO): a review of four cases.
    Keast DH; Fraser C
    Ostomy Wound Manage; 2004 Oct; 50(10):64-70. PubMed ID: 15509883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepcidin in anemia and inflammation in chronic kidney disease.
    Malyszko J; Mysliwiec M
    Kidney Blood Press Res; 2007; 30(1):15-30. PubMed ID: 17215586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anemia of chronic disease.
    Sears DA
    Med Clin North Am; 1992 May; 76(3):567-79. PubMed ID: 1578957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anemia and chronic heart failure implications and treatment options.
    Anand IS
    J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnosis and therapy of anemia in chronic diseases].
    Scudla V; Adam Z; Scudlová M
    Vnitr Lek; 2001 Jun; 47(6):400-6. PubMed ID: 11494888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The clinical significance of hepcidin detection in the patients with anemia and rheumatoid arthritis].
    Galushko EA
    Klin Med (Mosk); 2014; 92(6):21-7. PubMed ID: 25799826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.
    Opasich C; Cazzola M; Scelsi L; De Feo S; Bosimini E; Lagioia R; Febo O; Ferrari R; Fucili A; Moratti R; Tramarin R; Tavazzi L
    Eur Heart J; 2005 Nov; 26(21):2232-7. PubMed ID: 15987710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenesis and treatment of the anemia of chronic disease.
    Krantz SB
    Am J Med Sci; 1994 May; 307(5):353-9. PubMed ID: 8172230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erythropoiesis in multiply injured patients.
    Robinson Y; Hostmann A; Matenov A; Ertel W; Oberholzer A
    J Trauma; 2006 Nov; 61(5):1285-91. PubMed ID: 17099548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines.
    Inoue Y; Tsushima H; Ando K; Sawayama Y; Sakai M; Yamasaki R; Matsuo E; Tsutsumi C; Imaizumi Y; Iwanaga M; Imanishi D; Taguchi J; Miyazaki Y; Tomonaga M
    Exp Hematol; 2006 Jan; 34(1):19-26. PubMed ID: 16413387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [ANEMIA OF CHRONIC DISEASES AS A SYSTEMIC MANIFESTATION OF CHRONIC PULMONARY OBSTRUCTIVE DISEASE].
    Budnevsky AV; Voronina EV; Ovsyannikov ES; Tsvetikova LN; Zhusina YG; Labzhaniya NB
    Klin Med (Mosk); 2017; 95(3):201-6. PubMed ID: 30303337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anemia in critical illness.
    Eckardt KU
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):84-9. PubMed ID: 11253745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis.
    Fischer R; Simmerlein R; Huber RM; Schiffl H; Lang SM
    Pediatr Pulmonol; 2007 Dec; 42(12):1193-7. PubMed ID: 17948283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proinflammatory state and circulating erythropoietin in persons with and without anemia.
    Ferrucci L; Guralnik JM; Woodman RC; Bandinelli S; Lauretani F; Corsi AM; Chaves PH; Ershler WB; Longo DL
    Am J Med; 2005 Nov; 118(11):1288. PubMed ID: 16271918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.